US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist
  • 7.100
  • -0.100-1.39%
Close Aug 23 16:00 ET
132.43MMarket Cap-5503P/E (TTM)

Nuvectis Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-19.56%4.64M
7.19%4.4M
19.04%22.9M
1.30%6.87M
3.70%6.16M
61.54%5.77M
39.25%4.1M
49.17%19.23M
199.25%6.78M
27.21%5.94M
Selling and administrative expenses
12.58%1.7M
0.12%1.74M
25.14%7.52M
9.24%2.6M
17.91%1.67M
41.39%1.51M
52.11%1.73M
79.37%6.01M
112.40%2.38M
176.95%1.42M
-General and administrative expense
12.58%1.7M
0.12%1.74M
25.14%7.52M
9.24%2.6M
17.91%1.67M
41.39%1.51M
52.11%1.73M
79.37%6.01M
112.40%2.38M
176.95%1.42M
Research and development costs
-30.95%2.94M
12.38%2.66M
16.28%15.38M
-3.00%4.27M
-0.75%4.49M
70.14%4.26M
31.14%2.37M
38.58%13.23M
284.35%4.4M
8.76%4.52M
Operating profit
19.56%-4.64M
-7.19%-4.4M
-19.04%-22.9M
-1.30%-6.87M
-3.70%-6.16M
-61.54%-5.77M
-39.25%-4.1M
-49.17%-19.23M
-199.25%-6.78M
-27.21%-5.94M
Net non-operating interest income expense
235.94%215K
332.69%225K
327.52%637K
197.56%244K
354.10%277K
1,500.00%64K
2,500.00%52K
3,625.00%149K
1,950.00%82K
61K
Non-operating interest income
235.94%215K
332.69%225K
327.52%637K
197.56%244K
354.10%277K
1,500.00%64K
2,500.00%52K
3,625.00%149K
1,950.00%82K
--61K
Other net income (expense)
Income before tax
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
Income tax
Net income
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
Net income continuous Operations
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
Minority interest income
Net income attributable to the parent company
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
Basic earnings per share
31.58%-0.26
7.41%-0.25
5.30%-1.43
14.58%-0.41
11.90%-0.37
-35.71%-0.38
15.63%-0.27
-38.44%-1.51
-150.89%-0.48
-6.33%-0.42
Diluted earnings per share
31.58%-0.26
7.41%-0.25
5.30%-1.43
14.58%-0.41
11.90%-0.37
-35.71%-0.38
15.63%-0.27
-38.44%-1.51
-150.89%-0.48
-6.33%-0.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -19.56%4.64M7.19%4.4M19.04%22.9M1.30%6.87M3.70%6.16M61.54%5.77M39.25%4.1M49.17%19.23M199.25%6.78M27.21%5.94M
Selling and administrative expenses 12.58%1.7M0.12%1.74M25.14%7.52M9.24%2.6M17.91%1.67M41.39%1.51M52.11%1.73M79.37%6.01M112.40%2.38M176.95%1.42M
-General and administrative expense 12.58%1.7M0.12%1.74M25.14%7.52M9.24%2.6M17.91%1.67M41.39%1.51M52.11%1.73M79.37%6.01M112.40%2.38M176.95%1.42M
Research and development costs -30.95%2.94M12.38%2.66M16.28%15.38M-3.00%4.27M-0.75%4.49M70.14%4.26M31.14%2.37M38.58%13.23M284.35%4.4M8.76%4.52M
Operating profit 19.56%-4.64M-7.19%-4.4M-19.04%-22.9M-1.30%-6.87M-3.70%-6.16M-61.54%-5.77M-39.25%-4.1M-49.17%-19.23M-199.25%-6.78M-27.21%-5.94M
Net non-operating interest income expense 235.94%215K332.69%225K327.52%637K197.56%244K354.10%277K1,500.00%64K2,500.00%52K3,625.00%149K1,950.00%82K61K
Non-operating interest income 235.94%215K332.69%225K327.52%637K197.56%244K354.10%277K1,500.00%64K2,500.00%52K3,625.00%149K1,950.00%82K--61K
Other net income (expense)
Income before tax 22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M
Income tax
Net income 22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M
Net income continuous Operations 22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M
Minority interest income
Net income attributable to the parent company 22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M
Basic earnings per share 31.58%-0.267.41%-0.255.30%-1.4314.58%-0.4111.90%-0.37-35.71%-0.3815.63%-0.27-38.44%-1.51-150.89%-0.48-6.33%-0.42
Diluted earnings per share 31.58%-0.267.41%-0.255.30%-1.4314.58%-0.4111.90%-0.37-35.71%-0.3815.63%-0.27-38.44%-1.51-150.89%-0.48-6.33%-0.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg